- Home
- CAAS vs TARA Comparison
CAAS vs TARA Comparison
Compare CAAS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAS
- TARA
- Stock Information
- Founded
- CAAS N/A
- TARA N/A
- Country
- CAAS China
- TARA United States
- Employees
- CAAS N/A
- TARA N/A
- Industry
- CAAS Auto Parts:O.E.M.
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAAS Consumer Discretionary
- TARA Health Care
- Exchange
- CAAS Nasdaq
- TARA Nasdaq
- Market Cap
- CAAS 137.0M
- TARA 136.3M
- IPO Year
- CAAS N/A
- TARA N/A
- Fundamental
- Price
- CAAS $4.17
- TARA $4.01
- Analyst Decision
- CAAS
- TARA Strong Buy
- Analyst Count
- CAAS 0
- TARA 4
- Target Price
- CAAS N/A
- TARA $22.67
- AVG Volume (30 Days)
- CAAS 59.0K
- TARA 223.1K
- Earning Date
- CAAS 03-28-2025
- TARA 03-05-2025
- Dividend Yield
- CAAS N/A
- TARA N/A
- EPS Growth
- CAAS N/A
- TARA N/A
- EPS
- CAAS 0.99
- TARA N/A
- Revenue
- CAAS $650,935,000.00
- TARA N/A
- Revenue This Year
- CAAS $4.97
- TARA N/A
- Revenue Next Year
- CAAS N/A
- TARA N/A
- P/E Ratio
- CAAS $4.46
- TARA N/A
- Revenue Growth
- CAAS 12.94
- TARA N/A
- 52 Week Low
- CAAS $3.34
- TARA $1.60
- 52 Week High
- CAAS $5.37
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- CAAS 41.76
- TARA 43.01
- Support Level
- CAAS $4.17
- TARA $4.41
- Resistance Level
- CAAS $5.37
- TARA $4.63
- Average True Range (ATR)
- CAAS 0.27
- TARA 0.27
- MACD
- CAAS -0.03
- TARA -0.02
- Stochastic Oscillator
- CAAS 5.44
- TARA 5.30
About CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).